SAFRAN SA (SAF.PA)

FR0000073272 - Common Stock

216.5  -1.2 (-0.55%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
15.133B
-9.01%
19.523B
29.01%
23.651B
21.14%
27.73B
17.25%
EBITDA
YoY % growth
2.533B
-11.59%
4.057B
60.17%
4.6B
13.38%
5.39B
17.17%
EBIT
YoY % growth
1.153B
-18.69%
2.684B
132.78%
3.264B
21.61%
4.122B
26.29%
Operating Margin
7.62%13.75%13.80%14.86%
EPS
YoY % growth
1.73
-9.90%
2.68
54.91%
4.70
75.37%
7.01
49.09%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q4 / 24
EPS
Q2Q % growth
3.20
33.40%
Revenue
Q2Q % growth
12.943B
18.25%
EBITDA
Q2Q % growth
2.468B
18.43%
EBIT
Q2Q % growth
1.793B
25.30%

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
2.30
57.53%
2.90-0.60-20.65%
Q2 2023
Q2Q % growth
2.40
96.72%
2.280.125.45%
Q4 2022
Q2Q % growth
1.46
30.36%
2.39-0.93-38.96%
Q2 2022
Q2Q % growth
1.22
100.00%
1.48-0.26-17.83%
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
12.254B
12.96%
12.55B-296M-2.36%
Q2 2023
Q2Q % growth
10.945B
26.17%
10.898B47M0.43%
Q4 2022
Q2Q % growth
10.848B
29.70%
10.509B339M3.23%
Q2 2022
Q2Q % growth
8.675B
28.16%
8.491B184M2.17%
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q2 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 4.16%
RevenueN/A N/A 0% 2.99%